share_log

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities-Director Rice Derica W

Bristol-Myers Squibb | 4: Statement of changes in beneficial ownership of securities

施貴寶 | 4：持股變動聲明
SEC announcement ·  04/02 18:46
Moomoo AI 已提取核心訊息
Derica W. Rice, a reporting person for Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on March 31, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Rice to the issuer was also not specified. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
Derica W. Rice, a reporting person for Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on March 31, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Rice to the issuer was also not specified. Investors are advised to seek additional information to fully understand the impact of this event on their investment decisions.
百時美施貴寶（BMY）的舉報人德里卡·賴斯於2024年3月31日參與了該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。賴斯與發行人的關係也沒有具體說明。建議投資者尋求更多信息，以充分了解該事件對其投資決策的影響。
百時美施貴寶（BMY）的舉報人德里卡·賴斯於2024年3月31日參與了該公司股票的交易。公告中未披露該交易的具體細節，包括股票數量、股票性質、交易價格和股票總價值。賴斯與發行人的關係也沒有具體說明。建議投資者尋求更多信息，以充分了解該事件對其投資決策的影響。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息